Frederique Menzaghi Ph.D., Chief Scientific Officer, SVP-R&D at Cara Therapeutics, Inc. (CARA), sold 10,006 shares at $19.33 ($193K) on 2021-02-25, disclosed to the SEC on 2021-02-25.
Seasonal sale ($193k) by Chief Scientific Officer, SVP-R&D — this insider has traded CARA in February in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $19.33 | 5,003 | $97K | 50.0% |
| 2 | $19.33 | 5,003 | $97K | 50.0% |
| Total | $19.33 avg | 10,006 | $193K | 100% |
| Filing → |
| CARA | SELL | 2023-03-07 | $132K | — | Filing → |
| CARA | SELL | 2022-12-23 | $40K | — | Filing → |
| CARA | SELL | 2022-04-05 | $21K | — | Filing → |